Epigenomics AG

Marktkapitalisierung: 5.725.055,00
Materieller Buchwert: 22.060.000,00
Epigenomics Investor Relations

Financial Reports:

2021 Y: Epigenomics_AG_Annually_2021_IFRS_11_03_2022
2020 Y: Epigenomics_AG_Annually_2020_IFRS_12_03_2021
2019 Y: Epigenomics_AG_Annually_2019_IFRS_01_04_2020
2018 Y: Epigenomics_AG_Annually_2018_IFRS_20_03_2019
2017 Y: Epigenomics_AG_Annually_2017_IFRS_16_03_2018
2016 Y: Epigenomics_AG_Annually_2016_IFRS_03_04_2017
2015 Y: Epigenomics_AG_Annually_2015_IFRS_16_03_2016
2014 Y: Epigenomics_AG_Annually_2014_IFRS_10_03_2015
2013 Y: Epigenomics_AG_Annually_2013_IFRS_25_02_2014
2012 Y: Epigenomics_AG_Annually_2012_IFRS_06_03_2013
2011 Y: Epigenomics_AG_Annually_2011_IFRS_29_02_2012
2010 Y: Epigenomics_AG_Annually_2010_IFRS_01_03_2011

Anzahl der Aktien: 1

DE000A3H2184